This Week’s Biotech Highlights

A contentious policy week on both sides of the border:

Meanwhile, scientific progress refused to notice the controversies (or the recession):

Read more about these developments, as well as the Monday Deal Review, the Wednesday Brain Dump and the Friday Science Review at the Cross-Border Biotech Blog.

Comments are closed.